Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Newhook

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|November 23, 2018
Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right HepatectomyKatharina Joechle, Eduardo A Vega, Masayuki Okuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic CancerAlex D Michaels, Timothy E Newhook, Sara J Adair, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Annals of Surgery|December 1, 2018
Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After PancreatectomyTimothy E Newhook, Timothy J Vreeland, Whitney L Dewhurst, et al.
Annals of Surgical Oncology|February 10, 2021
Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder CancerPhillip M Kemp Bohan, Anne E O'Shea, Oriana V Ellis, et al.
Annals of Surgery|June 20, 2026
5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer SurgeryBrittany C Fields, Timothy E Newhook, Heather A Lillemoe, et al.
Surgical Oncology|January 8, 2021
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodesPhillip M Kemp Bohan, Anne E O'Shea, Andrew J Lee, et al.
Annals of Surgical Oncology|December 26, 2023
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver MetastasesArtem Boyev, Ching-Wei D Tzeng, Harufumi Maki, et al.
Neoplasia (New York, N.Y.)|February 27, 2013
Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinibDustin M Walters, James M Lindberg, Sara J Adair, et al.
Cancers|February 13, 2025
Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched AnalysisYongwoo David Seo, Belkacem Acidi, Andrew Newton, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|November 23, 2018
Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right HepatectomyKatharina Joechle, Eduardo A Vega, Masayuki Okuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic CancerAlex D Michaels, Timothy E Newhook, Sara J Adair, et al.
Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.
Annals of Surgery|December 1, 2018
Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After PancreatectomyTimothy E Newhook, Timothy J Vreeland, Whitney L Dewhurst, et al.
Annals of Surgical Oncology|February 10, 2021
Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder CancerPhillip M Kemp Bohan, Anne E O'Shea, Oriana V Ellis, et al.
Annals of Surgery|June 20, 2026
5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer SurgeryBrittany C Fields, Timothy E Newhook, Heather A Lillemoe, et al.
Surgical Oncology|January 8, 2021
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodesPhillip M Kemp Bohan, Anne E O'Shea, Andrew J Lee, et al.
Annals of Surgical Oncology|December 26, 2023
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver MetastasesArtem Boyev, Ching-Wei D Tzeng, Harufumi Maki, et al.
Neoplasia (New York, N.Y.)|February 27, 2013
Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinibDustin M Walters, James M Lindberg, Sara J Adair, et al.
Cancers|February 13, 2025
Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched AnalysisYongwoo David Seo, Belkacem Acidi, Andrew Newton, et al.
Pageof 12